世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Blood Irradiation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Blood Irradiation was estimated to be worth US$ 95.6 million in 2024 and is forecast to a readjusted size of US$ 125 million by 2031 with a CAGR of 3.4% during the forecast pe... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryThe global market for Blood Irradiation was estimated to be worth US$ 95.6 million in 2024 and is forecast to a readjusted size of US$ 125 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.Irradiation of human blood is used to avoid the TA-GVHD (transfusion-associated graft-versus-host-disease), a rare but devastating adverse effect of leukocytes present in blood component for immunocompetent transfusion recipients. It is worth noting that cesium and X-ray irradiators are devices dedicated to blood irradiation, usually operated by specialized institutions or departments external to the healthcare facilities that are actually using the irradiated blood (and thus have to purchase it from the irradiation service providers); in contrast, many user facilities already have LINACs and cobalt sources for cancer therapy and other treatments. These units, although they are designed for other purposes, can be used for blood irradiation on a limited basis. For example, a blood bag holder can be placed where a patient would be exposed and the LINAC operated to irradiate the blood instead of a person. The primary drivers of the blood irradiation market is the rising prevalence of immune-compromised conditions, such as cancer, organ transplant, and autoimmune diseases. These conditions often require blood transfusions, where blood irradiation can prevent transfusion-associated graft-versus-host disease (TA-GVHD). Additionally, advancements in blood irradiation technology and increased healthcare spending globally are boosting market demand. Regulatory agencies in many regions have also established strict guidelines to ensure the safety of blood transfusions, promoting the adoption of blood irradiation equipment in hospitals and blood banks. A significant challenge for the blood irradiation market is the high cost associated with irradiation equipment and maintenance. These expenses can be prohibitive for smaller healthcare facilities and blood banks, limiting adoption in low-resource settings. Another challenge is the growing availability of alternative methods for blood sterilization and immunomodulation, which compete with blood irradiation. Regulatory barriers and the need for extensive training and specialized staff for handling irradiation equipment further add to the cost and operational complexity, impacting market growth, particularly in developing countries. Global Blood Irradiation key players include Best Theratronics, Fujifilm, Gilardoni, Gamma-Service, etc. Global top four manufacturers hold a share about 70%. North America is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent. In terms of product, Gamma-ray Blood Irradiation is the largest segment, with a share over 50%. And in terms of application, the largest application is Blood Bank, followed by Hospital, Research Institutions. This report aims to provide a comprehensive presentation of the global market for Blood Irradiation, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Blood Irradiation by region & country, by Type, and by Application. The Blood Irradiation market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Irradiation. Market Segmentation By Company Best Theratronics Fujifilm Gilardoni Eckert & Ziegler Actemium WEGO (Rad Source) Shinva Medical LIVZON Segment by Type X-ray Blood Irradiation Gamma-ray Blood Irradiation Segment by Application Blood Bank Hospital Research Institutions By Region North America United States Canada Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia-Pacific Europe Germany France U.K. Italy Netherlands Nordic Countries Rest of Europe Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Chapter Outline Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 2: Detailed analysis of Blood Irradiation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Sales, revenue of Blood Irradiation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world. Chapter 6: Sales, revenue of Blood Irradiation in country level. It provides sigmate data by Type, and by Application for each country/region. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 9: Conclusion. Table of Contents1 Market Overview1.1 Blood Irradiation Product Introduction 1.2 Global Blood Irradiation Market Size Forecast 1.2.1 Global Blood Irradiation Sales Value (2020-2031) 1.2.2 Global Blood Irradiation Sales Volume (2020-2031) 1.2.3 Global Blood Irradiation Sales Price (2020-2031) 1.3 Blood Irradiation Market Trends & Drivers 1.3.1 Blood Irradiation Industry Trends 1.3.2 Blood Irradiation Market Drivers & Opportunity 1.3.3 Blood Irradiation Market Challenges 1.3.4 Blood Irradiation Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Blood Irradiation Players Revenue Ranking (2024) 2.2 Global Blood Irradiation Revenue by Company (2020-2025) 2.3 Global Blood Irradiation Players Sales Volume Ranking (2024) 2.4 Global Blood Irradiation Sales Volume by Company Players (2020-2025) 2.5 Global Blood Irradiation Average Price by Company (2020-2025) 2.6 Key Manufacturers Blood Irradiation Manufacturing Base and Headquarters 2.7 Key Manufacturers Blood Irradiation Product Offered 2.8 Key Manufacturers Time to Begin Mass Production of Blood Irradiation 2.9 Blood Irradiation Market Competitive Analysis 2.9.1 Blood Irradiation Market Concentration Rate (2020-2025) 2.9.2 Global 5 and 10 Largest Manufacturers by Blood Irradiation Revenue in 2024 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Irradiation as of 2024) 2.10 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 X-ray Blood Irradiation 3.1.2 Gamma-ray Blood Irradiation 3.2 Global Blood Irradiation Sales Value by Type 3.2.1 Global Blood Irradiation Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global Blood Irradiation Sales Value, by Type (2020-2031) 3.2.3 Global Blood Irradiation Sales Value, by Type (%) (2020-2031) 3.3 Global Blood Irradiation Sales Volume by Type 3.3.1 Global Blood Irradiation Sales Volume by Type (2020 VS 2024 VS 2031) 3.3.2 Global Blood Irradiation Sales Volume, by Type (2020-2031) 3.3.3 Global Blood Irradiation Sales Volume, by Type (%) (2020-2031) 3.4 Global Blood Irradiation Average Price by Type (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Blood Bank 4.1.2 Hospital 4.1.3 Research Institutions 4.2 Global Blood Irradiation Sales Value by Application 4.2.1 Global Blood Irradiation Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global Blood Irradiation Sales Value, by Application (2020-2031) 4.2.3 Global Blood Irradiation Sales Value, by Application (%) (2020-2031) 4.3 Global Blood Irradiation Sales Volume by Application 4.3.1 Global Blood Irradiation Sales Volume by Application (2020 VS 2024 VS 2031) 4.3.2 Global Blood Irradiation Sales Volume, by Application (2020-2031) 4.3.3 Global Blood Irradiation Sales Volume, by Application (%) (2020-2031) 4.4 Global Blood Irradiation Average Price by Application (2020-2031) 5 Segmentation by Region 5.1 Global Blood Irradiation Sales Value by Region 5.1.1 Global Blood Irradiation Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global Blood Irradiation Sales Value by Region (2020-2025) 5.1.3 Global Blood Irradiation Sales Value by Region (2026-2031) 5.1.4 Global Blood Irradiation Sales Value by Region (%), (2020-2031) 5.2 Global Blood Irradiation Sales Volume by Region 5.2.1 Global Blood Irradiation Sales Volume by Region: 2020 VS 2024 VS 2031 5.2.2 Global Blood Irradiation Sales Volume by Region (2020-2025) 5.2.3 Global Blood Irradiation Sales Volume by Region (2026-2031) 5.2.4 Global Blood Irradiation Sales Volume by Region (%), (2020-2031) 5.3 Global Blood Irradiation Average Price by Region (2020-2031) 5.4 North America 5.4.1 North America Blood Irradiation Sales Value, 2020-2031 5.4.2 North America Blood Irradiation Sales Value by Country (%), 2024 VS 2031 5.5 Europe 5.5.1 Europe Blood Irradiation Sales Value, 2020-2031 5.5.2 Europe Blood Irradiation Sales Value by Country (%), 2024 VS 2031 5.6 Asia Pacific 5.6.1 Asia Pacific Blood Irradiation Sales Value, 2020-2031 5.6.2 Asia Pacific Blood Irradiation Sales Value by Region (%), 2024 VS 2031 5.7 South America 5.7.1 South America Blood Irradiation Sales Value, 2020-2031 5.7.2 South America Blood Irradiation Sales Value by Country (%), 2024 VS 2031 5.8 Middle East & Africa 5.8.1 Middle East & Africa Blood Irradiation Sales Value, 2020-2031 5.8.2 Middle East & Africa Blood Irradiation Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Blood Irradiation Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions Blood Irradiation Sales Value and Sales Volume 6.2.1 Key Countries/Regions Blood Irradiation Sales Value, 2020-2031 6.2.2 Key Countries/Regions Blood Irradiation Sales Volume, 2020-2031 6.3 United States 6.3.1 United States Blood Irradiation Sales Value, 2020-2031 6.3.2 United States Blood Irradiation Sales Value by Type (%), 2024 VS 2031 6.3.3 United States Blood Irradiation Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe Blood Irradiation Sales Value, 2020-2031 6.4.2 Europe Blood Irradiation Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe Blood Irradiation Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China Blood Irradiation Sales Value, 2020-2031 6.5.2 China Blood Irradiation Sales Value by Type (%), 2024 VS 2031 6.5.3 China Blood Irradiation Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan Blood Irradiation Sales Value, 2020-2031 6.6.2 Japan Blood Irradiation Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan Blood Irradiation Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea Blood Irradiation Sales Value, 2020-2031 6.7.2 South Korea Blood Irradiation Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea Blood Irradiation Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia Blood Irradiation Sales Value, 2020-2031 6.8.2 Southeast Asia Blood Irradiation Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia Blood Irradiation Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India Blood Irradiation Sales Value, 2020-2031 6.9.2 India Blood Irradiation Sales Value by Type (%), 2024 VS 2031 6.9.3 India Blood Irradiation Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 Best Theratronics 7.1.1 Best Theratronics Company Information 7.1.2 Best Theratronics Introduction and Business Overview 7.1.3 Best Theratronics Blood Irradiation Sales, Revenue, Price and Gross Margin (2020-2025) 7.1.4 Best Theratronics Blood Irradiation Product Offerings 7.1.5 Best Theratronics Recent Development 7.2 Fujifilm 7.2.1 Fujifilm Company Information 7.2.2 Fujifilm Introduction and Business Overview 7.2.3 Fujifilm Blood Irradiation Sales, Revenue, Price and Gross Margin (2020-2025) 7.2.4 Fujifilm Blood Irradiation Product Offerings 7.2.5 Fujifilm Recent Development 7.3 Gilardoni 7.3.1 Gilardoni Company Information 7.3.2 Gilardoni Introduction and Business Overview 7.3.3 Gilardoni Blood Irradiation Sales, Revenue, Price and Gross Margin (2020-2025) 7.3.4 Gilardoni Blood Irradiation Product Offerings 7.3.5 Gilardoni Recent Development 7.4 Eckert & Ziegler 7.4.1 Eckert & Ziegler Company Information 7.4.2 Eckert & Ziegler Introduction and Business Overview 7.4.3 Eckert & Ziegler Blood Irradiation Sales, Revenue, Price and Gross Margin (2020-2025) 7.4.4 Eckert & Ziegler Blood Irradiation Product Offerings 7.4.5 Eckert & Ziegler Recent Development 7.5 Actemium 7.5.1 Actemium Company Information 7.5.2 Actemium Introduction and Business Overview 7.5.3 Actemium Blood Irradiation Sales, Revenue, Price and Gross Margin (2020-2025) 7.5.4 Actemium Blood Irradiation Product Offerings 7.5.5 Actemium Recent Development 7.6 WEGO (Rad Source) 7.6.1 WEGO (Rad Source) Company Information 7.6.2 WEGO (Rad Source) Introduction and Business Overview 7.6.3 WEGO (Rad Source) Blood Irradiation Sales, Revenue, Price and Gross Margin (2020-2025) 7.6.4 WEGO (Rad Source) Blood Irradiation Product Offerings 7.6.5 WEGO (Rad Source) Recent Development 7.7 Shinva Medical 7.7.1 Shinva Medical Company Information 7.7.2 Shinva Medical Introduction and Business Overview 7.7.3 Shinva Medical Blood Irradiation Sales, Revenue, Price and Gross Margin (2020-2025) 7.7.4 Shinva Medical Blood Irradiation Product Offerings 7.7.5 Shinva Medical Recent Development 7.8 LIVZON 7.8.1 LIVZON Company Information 7.8.2 LIVZON Introduction and Business Overview 7.8.3 LIVZON Blood Irradiation Sales, Revenue, Price and Gross Margin (2020-2025) 7.8.4 LIVZON Blood Irradiation Product Offerings 7.8.5 LIVZON Recent Development 8 Industry Chain Analysis 8.1 Blood Irradiation Industrial Chain 8.2 Blood Irradiation Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Blood Irradiation Sales Model 8.5.2 Sales Channel 8.5.3 Blood Irradiation Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
QYResearch社の 医療機器・消耗品分野 での最新刊レポート
本レポートと同じKEY WORD（blood）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
